Entering text into the input field will update the search result below

Oyster Point Pharma jumps 37% as Viatris agrees to acquire for $11/share in cash

Nov. 07, 2022 8:40 AM ETViatris Inc. (VTRS)By: Dulan Lokuwithana, SA News Editor19 Comments

word m and a made with wood building blocks, stock image

Maksim Labkouski

Updated to add latest share price moves

  • Oyster Point Pharma (NASDAQ:OYST), a company focused on eye disorders, announced Monday that Viatris (NASDAQ:VTRS) agreed to acquire it for $11.00 per share in cash plus a contingent

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.